Boehringer Ingelheim Pharmaceuticals, Inc. 2019-2021 Medical Affairs and Scientific Communications Fellowship About Us

The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer (1861-1939) in Ingelheim, Germany. From its beginnings in 1885 when it employed just 28 people in Nieder-Ingelheim, the company has since become a global enterprise.

Boehringer Ingelheim was established in the United States in 1971. Our U.S. headquarters are based in Ridgefield, Connecticut, with 16 additional locations throughout the United States. People with Purpose

At Boehringer Ingelheim, we recognize that our strength and competitive advantage are, in part, the result of our commitment to sustaining an organization that encourages diversity in all aspects of the business, whether that be in the diversity of the background of our employees, of thoughts and ideas, or in the diversity of our partners and suppliers.

The commitment, competence, and creative power of our people, sustained for well over a century, have made Boehringer Ingelheim a first-class, fast-growing pharmaceutical corporation. This is reflected in the energy and innovation of approximately 50,000 employees.

We offer our employees demanding and challenging tasks, and the appropriate opportunities for development and career advancement at national and international levels.

Value through Innovation A Culture of Responsibility & Commitment

As a privately-held pharmaceutical company, Boehringer Ingelheim is At Boehringer Ingelheim, we recognize that we are part of a focused on science that leads to more health for our patients and global community and our family of employees feels strongly their families. The discovery and development of innovative about partnering with organizations to improve it. medicines is fundamental to our continued growth and success. Our blueprint for innovation is tailored to accelerate the delivery of The ethical principles that have guided Boehringer Ingelheim breakthrough medicines to the patients we serve by for more than 130 years have created a culture of corporate integrating research, pre-clinical and early clinical development, social responsibility and commitment. translational medicine, and external partnering functions. This fusion of expertise combined with a dynamic research approach and an increased emphasis on external collaborations means we can Through the Boehringer Ingelheim Cares Foundation, we offer effectively incubate the most creative ideas and be among the programs that strengthen our communities, including: pioneers in emerging fields of medicine. • Patient Assistance Program The cornerstone of our research into new medicines is focused on • Global Product Donation Program those disease areas where we have built significant expertise over time. We are concentrating our research efforts and investment in • Financial Contributions Program these key therapeutic areas: • Employee Skills-Based Volunteer Program

Our Areas of Research & Development: Our mission is to help patients, serve our customers, and produce innovative research and scientific advancements to impact the • Cardio-Metabolic diseases millions of people who rely on us. Simply put, we are committed • Central Nervous System diseases to doing the right thing—for our patients, our customers, our • Immunology and Respiratory diseases communities, our employees, and everyone we serve. Oncology and Cancer Immunology • For more information on • Biosimilars Boehringer Ingelheim, please visit: http://www.boehringer-ingelheim.us Select Awards Twitter: https://twitter.com/boehringerus Science Magazine Top Employer (2004–2016) Facebook: Working Mother 100 Best Companies (2010, 2012, 2014-2016) https://www.facebook.com/boehringerus YouTube: Best Places to Work for LGBT Equality (2007-2012, 2014-2016) https://www.youtube.com/user/boehringerus National Association of Female Executives (NAFE) LinkedIn: Top 50 Company (2011, 2014-2016) https://www.linkedin.com/company/boehringer-ingelheim/ Top 10 Companies for People with Disabilities, Diversity Inc. (2014)

Top 25 Noteworthy Company, Diversity Inc. (2011– 2015) 2 Medical Affairs and Scientific Communications Fellowship Program Rotational Experiences

Boehringer Ingelheim is proud to offer a 2-year, rotation-based, Fellowship program within Clinical Development and Medical Affairs The Fellow will have an opportunity to participate in multiple Other rotations can be arranged based on availability and (CDMA). This design provides pharmacists with broad U.S. Medical Affairs exposure. The program will allow Fellows to develop the rotations with other Boehringer Ingelheim departments. interest of the Fellow. As part of the Fellowship program, competencies necessary to engage in comprehensive Medical activities within CDMA. Fellows will be based at Boehringer Ingelheim’s Potential electives include, but are not limited to: Fellows will gain numerous development opportunities by: U.S. headquarters in Ridgefield, CT and will complete 9-months each in Medical Strategy and Scientific Communications. Additionally, • Field-Based Medicine • Leading and executing a longitudinal research project to Fellows will complete 6 months of elective rotational experiences in one or more areas outside of CDMA through which they will gain improve medical processes and presenting the outcomes at Health Economics and Outcomes Research an understanding of the broad range of opportunities available within the pharmaceutical industry. • a national medical conference • Market Research • Enhancing leadership and management skills by precepting Medical Strategy • Marketing/Commercial Advanced Pharmacy Practice Experience students • Medical Education Gaining an understanding of corporate structure, regulatory As part of their experience, Fellows will: • • Patient Advocacy considerations and the drug development process Actively participate in therapeutic area development, execution, and strategic alignment of U.S. Medical and brand tactics • • Publications • Networking across Boehringer Ingelheim to learn about Develop cross-functional project management skills by partnering with internal and external stakeholders to support U.S. various opportunities in the pharmaceutical industry and • Regulatory Affairs Medical Information and Publication teams • participating in skills-based volunteerism Trade Relations • Gain experience in planning and executing advisory board meetings and engaging Key External Experts (KEEs) • • Develop educational materials, train internal Medical team members, and disseminate data from scientific manuscripts, congresses, etc. • Collaborate cross-functionally with internal and external colleagues to plan and implement educational programs at national conferences • Participate in the medical review of promotional and non-promotional materials as part of a multidisciplinary team Scientific Communications

As part of their experience, Fellows will: • Provide complete, accurate, balanced and referenced responses to medical information inquiries from healthcare professionals and patients • Maintain a comprehensive product response database as well as contribute to the development of managed care formulary dossiers • Conduct tailored product trainings that meet the needs of diverse audiences (e.g. Call Center personnel, field-based representatives) • Participate in the medical review of promotional and non-promotional materials as part of a multidisciplinary team (e.g., Grant Review Committees, Human Pharma Review Committees) • Contribute to the strategy and development of publications for major journal manuscripts, Congress posters and presentations • Collaborate with Medical Strategy for the review of Investigator-Initiated Studies (IIS) and Independent Medical Education proposals

3 4 Executive Sponsor Primary Fellowship Program Preceptors

Michael Kavanaugh Asha Philip, PharmD Executive Director, Scientific Communications and Strategic Engagement Fellowship Program Director Mike started his career at Boehringer Ingelheim in 1989 as a Asha received her Doctor of Pharmacy degree from Ernest Mario School of Pharmacy, Rutgers member of the Biometrics and Data Management team. After six University. Prior to joining Boehringer Ingelheim, Asha worked as a senior medical writer at Ogilvy years in the Medical department where he worked on supporting CommonHealth Worldwide, LLC (OCHWW). During her time at OCHWW, Asha gained a wealth New Drug Applications and managed a group of clinical applica- of experience in the development of high quality medical affairs and publications content in a tion programmers, he joined the commercial side of the business number of therapeutic areas including respiratory, neurology, cardiovascular, facial aesthetics, in various roles ranging from Competitive Intelligence, Business and infectious diseases. As a Certified Medical Publication Professional, Asha was also heavily Development, Sales/Marketing Effectiveness, and Marketing involved in strategic planning, research, drafting, and editing documents in preparation for Operations. In 2008, Mike joined the Respiratory Marketing team journal submissions. Currently, Asha is a Senior Associate Director in Medical Information and as Executive Director led five Boehringer Ingelheim respira- at Boehringer Ingelheim, responsible for the Specialty Respiratory, Oncology, Immunology, tory brands, managing Boehringer Ingelheim’s largest brand and Biosimilar portfolio. Since September 2016, Asha has been fulfilling responsibilities as a awareness campaign and launching a new inhaler product to the primary preceptor for the Post-Doctoral Fellowship Program, and is currently the Fellowship market. Program Director.

In 2014, Mike rejoined the Medical team in Clinical Development Harjeet Caberwal, PharmD and Medical Affairs. In his current role, Mike oversees the Scientific Harjeet received his Doctor of Pharmacy degree from the Ernest Mario School of Pharmacy, Communications team (including Medical Information and management Rutgers University. Following graduation, he began work as a medical writer for ICC Lowe. of the Medical Information Call Center, Publications, Medical Education, Harjeet eventually transitioned into medical strategy with the company and was the lead and External Research) and the Effectiveness and Stakeholder Relations medical director for a major cardiovascular account. In this capacity, he learned strategic teams. planning and developed a scientific understanding for the disease state and competitive landscape. In collaboration with his client, Harjeet led the development of peer-to-peer Mike has a Bachelor of Science in Biology and Psychology and an content, advisory boards, congress planning, speaker training, field force training, and a MBA in International Business and Information Systems. He enjoys variety of other projects to support the marketing teams. He also provided strategic help with mentoring and developing teams through gaining an understanding other accounts including transplant immunology, women’s health, and IBS. Harjeet joined of his team members’ developmental goals and applying his broad Boehringer Ingelheim as a Cardiovascular Medical Science Liaison before transitioning to experience across multiple functions in the pharmaceutical industry. the Cardiovascular CDMA team.

Craig Conoscenti, MD Craig received his undergraduate degree from Fordham University in New York. He received “The post-doctoral fellowship program at Boehringer Ingelheim serves to prepare pharmacy graduates for careers within the pharmaceutical his Doctorate in Medicine from St George’s University School of Medicine. He completed his industry. While the primary focus of our fellowship program was historically centered around Medical Information activities, we are excited residency and chief residency at Hackensack University Medical Center in New Jersey and a to expand our program to provide a broader experience within CDMA. Fellows will also have the opportunity to set up rotations in other fellowship in pulmonary and critical care medicine at Norwalk Hospital/Yale University School non-medical areas such as Drug Regulatory Affairs, Health Economics Outcomes Research and Trade Marketing and Sales. The fellowship of Medicine in Connecticut. Craig is board certified in Pulmonary and Critical Care Medicine. is a fantastic opportunity to gain a portfolio of valuable experience within the pharmaceutical industry. We pride ourselves on developing Prior to assuming his current role, Craig practiced in the clinical academic program at Norwalk well-rounded pharmacists who are equipped to make impactful contributions to the organization early in their careers. Boehringer Ingelheim Hospital for 17 years holding positions as director of the hyperbaric medicine division, senior consultant in pulmonary and critical care medicine as well as research physician in the Hinds is a family owned global company with a focus on effectively engaging with our customers. As the Sponsor of the fellowship program, I Center for Respiratory Research in Connecticut. Craig was also the faculty educator for both feel that the professionals who serve as mentors for our Fellows are the ones who drive our program’s success. Graduates from Boehringer the fellowship and residency training programs at Norwalk Hospital. Craig joined Boehringer Ingelheim’s Post-Doctoral Fellowship Program have gone on to have successful careers, including opportunities to further their professional Ingelheim in 2002 and served as the US Medical Affairs lead for the Spiriva program until growth and development here at Boehringer Ingelheim.” 2006, at which time, he was appointed the program lead for the pulmonary fibrosis program. Craig is currently Medical Expert in Specialty Clinical Development and Medical Affairs and the lead for the Chronic Fibrosing Interstitial Lung Disease program. Craig is a member and serves on special task force committees for the American Thoracic Society and American College of CHEST Physicians. He is a member of the European Respiratory Society. He received the Norman S Brady Fellowship, through which he served sabbatical time at the Brompton Chest Hospital in London, England. 5 6 Additional Preceptors

Joseph Abrajano, PhD Anita-Marie Holz, MSN, CRNP Joseph received his PhD in Neuroscience from the Albert Einstein College of Medicine. He joined Anita received a Bachelors of Science in Nursing from Messiah College in 1991 followed by a the Scientific Communications team as Associate Director, External Research in November 2017. Masters of Science in Nursing, Family Nurse Practitioner in 1997. She worked in the acute care Prior to working at Boehringer Ingelheim, Joseph was at Acorda Therapeutics, Inc. where he setting as a Cardiovascular Nurse Practitioner from 1997-2008. During her work as a Nurse was an Associate Manager in Scientific Communications. In that role, his experiences included Practitioner, she gained experience in the Electrophysiology lab at Lankenau hospital before scientific publications, advisory boards, medical education grants, and investigator initiated moving to Chester County Hospital where she assisted with the opening of the Interventional studies. Prior to that role, Joseph worked at various medical communications agencies, developing Cardiology and Cardiac Surgery program, as well as the development of the NP Intensivist scientific materials including slide kits, market research, and advisory board executive summaries. program. Anita left full-time clinical work to join the medical affairs department at Boehringer Ingelheim Pharmaceuticals in 2008. Starting her career at BI as a Medical Science Liaison, Anita joined the internal CDMA team in 2013 and now serves as the Cardiovascular Therapeutic Area Lead.

Christopher Cabrey, PharmD Neha Kapur, PharmD Chris earned his Doctor of Pharmacy degree from the Philadelphia College of Pharmacy. Following Neha earned her Doctor of Pharmacy degree from the University of Illinois at Chicago in graduation, Chris completed a 2-year post-doctoral fellowship in Medical Affairs with the Rutgers May 2016. Prior to graduation, Neha gained valuable pharmaceutical industry experience by Pharmaceutical Industry Fellowship Program at Acorda Therapeutics. During his fellowship, completing two summer internships at Takeda Pharmaceuticals in Regulatory Affairs (Advertising Chris gained a wealth of experience in the areas of Medical Information, Market Access, and and Promotion) and Medical Information and Review (MIR). As a MIR intern, Neha worked on Drug Safety and Risk Management. Chris went on to become a Medical Information Specialist several projects that improved medical information access to patients, health care providers at Acorda Therapeutics, where he developed various CNS-related medical content and served and payers. In June 2016, Neha joined Boehringer Ingelheim as the Medical Information Fellow as a primary reviewer for promotional materials. Chris is currently an Associate Director in and was a top 5 finalist for her research poster presented at the 2017 DIA Medical Affairs and Medical Information at Boehringer Ingelheim, supporting the Cardio-Metabolic portfolio. Scientific Communications Forum. Neha has continued her career with Boehringer Ingelheim as an Associate Director in Medical Information, supporting the Respiratory and Established products. She also serves as a primary preceptor for the Post-Doctoral Fellowship Program.

Meghan Colasanto, PharmD Melissa McGrath, PhD Meghan received her Doctorate in Pharmacy, Bachelor of Science in Physiology and Neuro- Melissa received her Bachelor of Science degree from Union College and earned her PhD in biology, and Bachelor of Science in Pharmacy Studies, all from the University of Connecticut. Immunology from the Weill Graduate School of Medical Sciences of Cornell University in New Meghan started her career in clinical pharmacy at Yale New Haven Hospital in 2006 with a York City. She then completed a post-doctoral fellowship within the Memorial Sloan- Ket- focus in Critical Care and later transitioned over to Internal Medicine serving as the Primary tering Molecular Pharmacology Program. Her work there focused on the discovery and devel- Preceptor for the ASHP-Accredited Pharmacy Residency Program. Meghan joined Boehringer opment of novel and specific immunotherapeutic agents while conducting and publishing Ingelheim in 2013 in the Medical Information Therapeutics group where she held increasing original research. Melissa then entered the field of scientific/medical communications were responsibilities as Associate Director and Program Director of the Medical Information Fellow- she had several roles in writing, editing, and leading the medical content and strategy for ship Program. Most recently, Meghan was at Alexion Pharmaceuticals, where her responsibili- continuing medical education and publications within the pharmaceutical industry. Melissa ties included Global Medical Information and operational oversight of the Global Access to came to Boehringer Ingelheim in 2010 when she took the lead for Metabolism Publications Medicines Program. In 2017, Meghan returned to Boehringer Ingelheim and currently serves and Communications, developing robust globally-aligned U.S. Strategic Publication Plans for as Associate Director in External Research, responsible for the Oncology Investigator- Initiated launch and pre-launch drugs across the Metabolism franchise. Since then, Melissa’s role has Studies (IIS) and External Collaborative Research (ECR) studies. grown to include Medical Communications of Innovative Immunology compounds, as well as Immunology/Oncology Biosimilars.

7 8 Additional Preceptors

Hetal Patel, PharmD Jacob Runyan, MSc, MBA Hetal received her Doctorate in Pharmacy from Mercer University, College of Pharmacy and Health Jake earned his Bachelor of Arts in Biology from Hiram College and his Master of Science in Sciences, Atlanta, GA. After graduation in 2002, she began her career in the pharmaceutical Molecular and Cell Biology, Master of Business Administration in Healthcare, and a Certifi- industry at Solvay Pharmaceuticals, Inc., where her experiences included medical information, cate in Healthcare Compliance from Quinnipiac University. Jake started his career in R&D medical publications, and product launch strategic planning and readiness. She also served as working in neuroscience at the University of Pennsylvania, oncology at a small biotech com- Co-Director of the Solvay-Mercer Drug Information Residency, precepting pharmacy residents pany, and cardiology at Boehringer Ingelheim. He then transitioned to a clinically-based role and interns. In 2005, Hetal joined Boehringer Ingelheim as Medical Science Liaison. Over her as a Medical Science Liaison and subsequently helped to develop the Boehringer Ingelheim 10 years as a member of the Field-Based Medicine team, she supported the Cerebrovascular Medical Publications department. Over the past ten years, Jake has held positions of increas- and Cardiovascular portfolios, serving as a scientific resource to scientific experts. Since 2015, ing responsibility at Acorda Therapeutics, where he helped to expand the Medical Affairs de- Hetal has served as an Associate Director of Scientific Communications Publications. In this partment from a team of two to thirty-five and was responsible for the creation of the Field- role, she leads the strategic direction, development, and execution of the U.S. Strategic and Based Medicine team. Jake recently returned to Boehringer Ingelheim and currently serves as Tactical Publication Plan for all medical and scientific publications in support of Boehringer Director of Scientific Communications. Ingelheim’s Cardiovascular, Oncology, Respiratory and CNS Portfolios.

Michaela Petrini, PA-C, MHS Manita Singh, PharmD Michaela received her Physician Assistant degree and Masters of Health Science from Quinnipiac Manita received her Doctor of Pharmacy degree from the University of Pittsburgh. She went on to University in Hamden, CT. Following graduation, she worked for several years as a Primary Care PA pursue a 2-year post-doctoral fellowship in US Managed Markets and Marketing with the Rutgers in Danbury, CT. Michaela transitioned into the pharmaceutical industry in 2005 when she joined Pharmaceutical Industry Fellowship Program and Sanofi in Bridgewater, NJ. Manita started her career Boehringer Ingelheim as a Clinical Drug Coordinator. Shortly after joining BI, Michaela moved with Boehringer Ingelheim in 2008 as a Medical Science Liaison, where she provided field-based to Clinical Operations where she held roles of increasing responsibility including global trial medical support in the CNS and Women’s Health therapeutic areas. Manita then joined the Medical clinical monitor for several studies within metabolism. Michaela explored other opportunities in Information team as a Manager from 2010 to 2016, where she was responsible for medical information biotech where she was the lead for clinical operations, medical writing and project management activities across a variety of brands within the CNS, Cardiovascular, and Respiratory portfolios. at Progenics, an oncology-focused company in Tarrytown, NY. She also gained experience as Manita served as a mentor for the 2016-2017 fellows research project, which was nominated a Senior Project Leader for a large CRO where she was responsible for a multi-national, Phase as a finalist (one of the top 5 2017 MASC Residents/Fellows posters) at the 2017 DIA Meeting. IV study that led to a successful sNDA for a Pfizer marketed compound. Michaela re-joined Currently, she is an Associate Director in Medical Education supporting Independent Medical BI in 2015 as part of the Cardiovascular CDMA team supporting Cardiovascular products and Education (IME), Scientific Advancement Grant (SAG) and Quality Improvement Education (QIE) pipeline for the US medical team. grant funding across specialty therapeutic areas including: Oncology, Biosimilars, Immunology, and Respiratory. Manita also serves as an adjunct faculty member at the Albany College of Pharmacy and Health Sciences, where she teaches a module on Medical Affairs in the Pharmaceutical Industry.

Eric Polistena, PharmD Sue Ellen Touma, PhD Eric received his Bachelor of Science degree in Pharmacy from St. John’s University and Sue Ellen received her Bachelor of Science degree in Biochemistry from Merrimack College his Doctor of Pharmacy degree from Creighton University. Earlier in his career, Eric worked and her PhD in Pharmacology from Weill Medical College of Cornell University. She has as a staff pharmacist at two hospitals in New York and one in Baltimore. He processed experience in preclinical, translational and clinical research as well as publications and 9 years medication orders, compounded IVs, TPNs and chemotherapy, staffed a NICU satellite, and of experience in medical education. For the 3 years prior to joining industry, Sue Ellen led a team responded to drug information inquiries. After leaving the hospital setting, Eric worked two responsible for content development, outcomes analyses and faculty management for CME years for a company responding to medical information requests for Pfizer and then joined programs for educational providers. Before joining Boehringer Ingelheim, she worked within Purdue Pharma in Medical Services prior to joining the Medical Information department at the US Medical Affairs organizations of Bristol-Myers Squibb and AstraZeneca developing and Boehringer Ingelheim in October 2006. Eric currently provides medical information services executing the independent medical education strategy in the diabetes, immuno-oncology, in the Metabolic therapeutic area. and for hematological malignancies. In her current role at Boehringer Ingelheim, Sue Ellen has assumed similar responsibilities within the Primary Care area, working with the diabetes, asthma and COPD teams as well as managing Scientific Advancement and Quality Improvement Education grants. She is a member of the Alliance for Continuing Education in the Health Professions.

7 8 Additional Preceptors Current Fellows Donald Zoz, MD Samuel Fu, PharmD, MS Don received his Doctorate in Medicine, cum laude, from The Ohio State University, where Sam earned his Doctor of Pharmacy degree from the University of Kentucky College of Pharmacy he also completed his residency in Internal Medicine. He then went on to complete his in May 2018 and his Master of Science in Biotechnology from Georgetown University. Prior to fellowship in Pulmonary & Critical Care Medicine at Vanderbilt University Medical Center, graduation, he gained valuable pharmaceutical industry experience through completing rotations studying IPF in the lab of Dr. Timothy Blackwell. Prior to his current role at Boehringer in the areas of Regulatory, Clinical Sciences, and Medical Information. Sam also has experience Ingelheim, Don was a Clinical Associate Professor of Medicine at Wright State University in developing landscape analyses to aid in early stage product development and preclinical College of Medicine and a Partner at Pulmonary & Critical Care Consultants in Dayton, laboratory experience. As a fellow, Sam provides medical and project management support OH. Don joined Boehringer Ingelheim in 2017 as Senior Associate Director of Clinical to the Medical Information, Education, and Publication team within the Cardio-Metabolic, Development & Medical Affairs for Respiratory, focusing on IPF / ILD, and currently is the Specialty Respiratory, and Immunology therapeutic area. US Medical Lead for the Systemic Sclerosis ILD Program at BI. Don is board certified in Internal Medicine, Pulmonary Medicine, Critical Care Medicine and he is also an active member of the American Thoracic Society, and a Member and Fellow in the American College of Chest Physicians.

Former Fellow Testimonals Nicole Silengo, PharmD, B.S. Nicole earned her Doctor of Pharmacy Degree from Western New England University in May “The Boehringer-Ingelheim Medical Information Fellowship was a memorable and invaluable experience that helped prepare me of 2018. Prior to graduation, Nicole gained experience in the pharmaceutical industry by completing a rotation with GlaxoSmithKline’s Consumer Health Medical Affairs team. As a for a successful career in the pharmaceutical industry. During my fellowship, I was afforded several unique opportunities, including current fellow at BI, Nicole primarily provides medical support to the Cardiovascular Therapeutic supporting the launch of a ground-breaking product and leading research related to a transformational project. The fellowship Area. Her responsibilities include collaborating with internal stakeholders on various projects exposed me to several disciplines within the pharmaceutical industry and gave me hands-on experience working within cross- for national conferences as well as planning and executing advisory board meetings. She functional teams. The program is specifically tailored to meet each fellow’s needs — my preceptors empowered me to mature my also develops educational materials and disseminates data from scientific literature to train existing strengths while simultaneously facilitating the improvement of my weaknesses. The entire Medical Information team was and educate field and internal Medical team members. Nicole enjoys participating in the engaged in my development and truly invested in my career growth. I strongly recommend this program to PharmD graduates seeking Human Pharma Review Committee and plays an active role in the strategic alignment of U.S to gain the necessary foundation for a rewarding career in medical information and the pharmaceutical industry.” Medical and brand tactics. She is also a member of Pharmacists Across BI, an organization Joy Lee, PharmD that connects pharmacists throughout the company. 2015-2016 Fellow

“The Boehringer Ingelheim Medical Information (MI) Fellowship was truly a rewarding, well-rounded experience that jump started my career within the pharmaceutical industry. Not only did I develop MI expertise across multiple therapeutic areas and execute valuable “The Medical Information Fellowship at Boehringer Ingelheim was an invaluable opportunity that allowed me to develop into a MI research, but I also gained hands-on experience in other functions, such as Payer and Health Systems Marketing. The breadth capable industry professional. As a fellow, I gained valuable experience working with various cross-functional teams to support the and depth of my experiences, along with the continuous support of my team, expedited my growth and ability to produce impactful Cardiovascular therapeutic area. Additionally, my preceptors encouraged and supported me in pursuing my interests in the areas of work. Post-fellowship, I am grateful for the opportunity to continue working with such a talented, collaborative and passionate group Business Development & Licensing, Field-Based Medicine, and Pipeline Marketing through a number of rotational and shadowing of individuals. Additionally, I greatly value being able to leverage MI insights across a growing number of opportunities to cross- experiences. Following completion of my fellowship, I am overjoyed to be able to continue my professional career at Boehringer functionally improve the customer experience and address unmet customer needs.” Ingelheim. I look forward to implementing and leveraging the skills I developed during my fellowship as I progress through my career to bring value to the organization.” Neha Kapur, PharmD 2016-2017 Fellow Allison Cui, PharmD 2017-2018 Fellow

9 10 Program Alumni: Where Are They Now? Salary and Benefits

2017 - 2018 2012 – 2013 Salary and Benefits Allison Cui, PharmD Brian Calamari, PharmD The fellow will receive a competitive stipend and benefits package. Medical Science Liaison, Cardiometabolic Medical Outcomes Science Liaison Boehringer Ingelheim Pharmaceuticals, Inc., AbbVie Inc., North Chicago, IL Application Requirements: Ridgefield, CT Research Project: “Evaluating Technology Products Research Project: “Communication Gaps Between Medical to Disseminate Medical Information” Doctor of Pharmacy degree from an ACPE-accredited school or college of pharmacy earned prior to Information and Other Internal Customer-Facing Teams the start date at Boehringer Ingelheim. 2011 – 2012 Across the Pharmaceutical Industry” Madhavi Patel, Pharm.D., R.Ph. • Interview at the ASHP’s Midyear Clinical Meeting (strongly recommended). 2016 - 2017 Associate Director, Medical Information Please submit an interview request via ASHP/PPS with your curriculum vitae (required) Neha Kapur, PharmD Novartis Pharmaceuticals Corporation and letter of intent (highly suggested). Associate Director, Medical Information Research Project: “Assessing the Satisfaction, Utility, • Must be legally authorized to work in the United States without restriction. Boehringer Ingelheim Pharmaceuticals, Inc., and Efficiency of a Recently Launched Global Medical Ridgefield, CT Information Repository” Research Project: “Evaluating Medical Information Data Select candidates who interview at Midyear will be asked to complete an online application and submit 2009 – 2010 th Utilization and Insights Across the Pharmaceutical Industry” the following by Friday, November 30 , 2018: Peter Zoob, PharmD, RPh 2015 – 2016 Senior Medical Science Liaison • Letter of intent Joy Lee, PharmD Vertex Pharmaceuticals, Boston, MA • Curriculum vitae (CV) Head, Medical Information Research Project: “Surveying Patient Use of the Internet Three letters of recommendation Portola Pharmaceuticals, Inc., South San Francisco, CA and Social Media as Medication Information Resources” • Research Project: “Globalization of Medical Information 2008 – 2009 Contact Person: at Boehringer Ingelheim: Challenges and Opportunities Ayesha Chaudhary (Ghias), PharmD of the Envision Project.” Asha Philip, PharmD Independent Contractor Fellowship Program Director 2014 – 2015 Research Project: “Development of a System to Update and Boehringer Ingelheim Pharmaceuticals, Inc. Michele Miller, PharmD Maintain an Inactive Ingredients Database for Products 900 Ridgebury Road Senior Manager, Medical Information within a Pharmaceutical Company” Ridgefield, CT 06877 US Oncology Medical 2006 – 2007 Novartis Pharmaceuticals Corporation, East Hanover, NJ Nada Abu-Shraie, PharmD Phone 203-798-4133 Research Project: “Evaluating the Role of Product Dossiers Consultant, Clinical Pharmacist – Drug Information Drug [email protected] on the Formulary Review Process” Policy & Economics Center 2013 – 2014 Ministry of National Guard Health Affairs King Abdulaziz Meghal Khokhani, PharmD Medical City, Riyadh, Saudi Arabia Medical Science Liaison, Immunology Research Project: “The Impact of Spiriva® Direct-To- AbbVie Inc., North Chicago, IL Consumer Advertisements on Promoting Medical Safety Research Project: “Evaluating Compliance Elements Awareness” Associated with Medical Information Websites”

11 12